Foreign Manufacturers Legal Accountability Act of 2015

PL 111-163: Caregiver and Veterans Omnibus Health Services Act; PL 112-56: 3% Withholding Repeal and Job Creation Act; PL 112-239: National Defense Authorization Act for FY2013; PL 112-56: VOW (Veterans Opportunity to Work) to Hire Heroes Act; S 1076/HR 2249: Disabled Military Child Protection Act of 2013; HR 3304: National Defense Authorization Act 2014; S 425/HR 474: Homeless Veterans' Reintegration Programs Reauthorization Act of 2015; S 851: Caregivers Expansion and Improvement Act; HR 294: Long-Term Care Veterans Choice Act; HR 2072: Demanding Accountability for Veterans Act of 2013; PL 113-146: Veterans Access, Choice and Accountability Act of 2014; PL 113-175: Department of Veterans Affairs Expiring Authorities Act of 2014; PL 113-360: National Defense Authorization Act; S 657 Caregivers Expansion & Improvement Act of 2015; S 1085: Military and Veteran Caregiver Services Improvement Act; HR 1843: To direct the Secretary of Veterans Affairs to establish a pilot program to improve access to supportive services and community coordination for families of disabled veterans; S 901/HR 1769: Toxic Exposure Research Act; S 2633: Improving Veterans Access to Care in the Community Act; S 2646: Veterans Choice Improvement Act of 2015; and S 2943: National Defense Authorization Act of FY2017.

Client expense: $157,721 · Firm income: Not reported

Government targets: Administration for Children & Families (ACF), Defense, Dept of (DOD), Education, Dept of, Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Council on Disability, SENATE, Transportation, Dept of (DOT), U.S. Architectural & Transportation Barriers Compliance Board (ACCESS), Veterans Affairs, Dept of (VA), White House Office

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

PL 111-163: Caregiver and Veterans Omnibus Health Services Act; PL 112-56: 3% Withholding Repeal and Job Creation Act; PL 112-239: National Defense Authorization Act for FY2013; PL 112-56: VOW (Veterans Opportunity to Work) to Hire Heroes Act; S 1076/HR 2249: Disabled Military Child Protection Act of 2013; HR 3304: National Defense Authorization Act 2014; S 425/HR 474: Homeless Veterans' Reintegration Programs Reauthorization Act of 2015; S 851: Caregivers Expansion and Improvement Act; HR 294: Long-Term Care Veterans Choice Act; HR 2072: Demanding Accountability for Veterans Act of 2013; PL 113-146: Veterans Access, Choice and Accountability Act of 2014; PL 113-175: Department of Veterans Affairs Expiring Authorities Act of 2014; PL 113-360: National Defense Authorization Act; S 657 Caregivers Expansion & Improvement Act of 2015; S 1085: Military and Veteran Caregiver Services Improvement Act; HR 1843: To direct the Secretary of Veterans Affairs to establish a pilot program to improve access to supportive services and community coordination for families of disabled veterans; S 901/HR 1769: Toxic Exposure Research Act; S 2633: Improving Veterans Access to Care in the Community Act; and S 2646: Veterans Choice Improvement Act of 2015.

Client expense: $71,499 · Firm income: Not reported

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 01-19-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 01-19-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. General lobbying with regard to consumer use and safety of unmanned aerial systems. H.R. 3669 (SAFE DRONE Act of 2015); amends title 18, United States Code, to provide a criminal penalty for operating drones in certain locations. General lobbying on aviation safety. H.R. 1062/S. 571 (Pilot's Bill of Rights 2); amends the Pilot's Bill of Rights to facilitate appeals and to apply to other certificates issued by the Federal Aviation Administration, to require the revision of the third class medical certification regulations issued by the Federal Aviation Administration.

PL 111-163: Caregiver and Veterans Omnibus Health Services Act; PL 112-56: 3% Withholding Repeal and Job Creation Act; PL 112-239: National Defense Authorization Act for FY2013; PL 112-56: VOW (Veterans Opportunity to Work) to Hire Heroes Act; S 1076/HR 2249: Disabled Military Child Protection Act of 2013; HR 3304: National Defense Authorization Act 2014; S 425/HR 474: Homeless Veterans' Reintegration Programs Reauthorization Act of 2015; S 851: Caregivers Expansion and Improvement Act; HR 294: Long-Term Care Veterans Choice Act; HR 2072: Demanding Accountability for Veterans Act of 2013; PL 113-146: Veterans Access, Choice and Accountability Act of 2014; PL 113-175: Department of Veterans Affairs Expiring Authorities Act of 2014; PL 113-360: National Defense Authorization Act; S 657 Caregivers Expansion & Improvement Act of 2015; S 1085: Military and Veteran Caregiver Services Improvement Act; HR 1843: To direct the Secretary of Veterans Affairs to establish a pilot program to improve access to supportive services and community coordination for families of disabled veterans; and S 901/HR 1769: Toxic Exposure Research Act.

Client expense: $73,347 · Firm income: Not reported

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-19-2015; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-19-2015; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. S. 1900/H.R. 3830 (Bipartisan Congressional Trade Priorities Act); establishes Congressional trade negotiating objectives and enhanced consultation requirements for trade negotiations, provides for consideration of trade agreements, and for other purposes. S. 2171 (Location Privacy Protection Act); specific interest in limitations on liability and preemption of state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 4921; provides for the revision of certification requirements for the labeling of certain electronic products under the Energy Star program. S. 2615; establishes criminal penalties for failing to inform and warn of serious dangers. H.R. 4 (Jobs for America Act); revises Federal law to improve the conditions necessary for economic growth and job creation. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 3020/S. 1695 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016); making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2016. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. General lobbying with regard to consumer use and safety of unmanned aerial systems. H.R. 3669 (SAFE DRONE Act of 2015); amends title 18, United States Code, to provide a criminal penalty for operating drones in certain locations. General lobbying on aviation safety.

PL 111-163: Caregiver and Veterans Omnibus Health Services Act; PL 112-56: 3% Withholding Repeal and Job Creation Act; PL 112-239: National Defense Authorization Act for FY2013; PL 112-56: VOW (Veterans Opportunity to Work) to Hire Heroes Act; S 1076/HR 2249: Disabled Military Child Protection Act of 2013; HR 3304: National Defense Authorization Act 2014; S 425/HR 474: Homeless Veterans' Reintegration Programs Reauthorization Act of 2015; S 851: Caregivers Expansion and Improvement Act; HR 294: Long-Term Care Veterans Choice Act; HR 2072: Demanding Accountability for Veterans Act of 2013; PL 113-146: Veterans Access, Choice and Accountability Act of 2014; PL 113-175: Department of Veterans Affairs Expiring Authorities Act of 2014; PL 113-360: National Defense Authorization Act; S 657 Caregivers Expansion & Improvement Act of 2015; S 1085: Military and Veteran Caregiver Services Improvement Act; HR 1843: To direct the Secretary of Veterans Affairs to establish a pilot program to improve access to supportive services and community coordination for families of disabled veterans; and S 901/HR 1769: Toxic Exposure Research Act.

Client expense: $60,790 · Firm income: Not reported

PL 111-163: Caregiver and Veterans Omnibus Health Services Act; PL 112-56: 3% Withholding Repeal and Job Creation Act; PL 112-239: National Defense Authorization Act for FY2013; PL 112-56: VOW (Veterans Opportunity to Work) to Hire Heroes Act; S 1076/HR 2249: Disabled Military Child Protection Act of 2013; HR 3304: National Defense Authorization Act 2014; HR 474: Homeless Veterans' Reintegration Programs Reauthorization Act of 2015; S 851: Caregivers Expansion and Improvement Act; HR 294: Long-Term Care Veterans Choice Act; HR 2072: Demanding Accountability for Veterans Act of 2013; PL 113-146: Veterans Access, Choice and Accountability Act of 2014; PL 113-175: Department of Veterans Affairs Expiring Authorities Act of 2014; PL 113-360: National Defense Authorization Act; S 657 Caregivers Expansion & Improvement Act of 2015; S 1085: Military and Veteran Caregiver Services Improvement Act; and HR 1843: To direct the Secretary of Veterans Affairs to establish a pilot program to improve access to supportive services and community coordination for families of disabled veterans.

Client expense: $64,746 · Firm income: Not reported

NIST Cybersecurity Framework; H.R. 3304: Information Sharing Legislation; Protecting Cyber Networks Act (H.R. 1560); National Cybersecurity Protection Advancement Act of 2015; Cyber Intelligence Sharing and Protection Act (H.R. 234; Cybersecurity Information Sharing Act of 2015 (S. 754); Cyber Threat Sharing Act of 2015 (S. 456) Data Security and Breach Notification Act of 2015; National data breach notification standard, and for other purposes (H.R. 1704)Data Security and Breach Notification Act of 2015 (S. 177); House

Client expense: Not reported · Firm income: $180,000

Government targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institute of Standards & Technology (NIST), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office

PL 111-163: Caregiver and Veterans Omnibus Health Services Act; PL 112-56: 3% Withholding Repeal and Job Creation Act; PL 112-239: National Defense Authorization Act for FY2013; PL 112-56: VOW (Veterans Opportunity to Work) to Hire Heroes Act; S 1076/HR 2249: Disabled Military Child Protection Act of 2013; HR 3304: National Defense Authorization Act 2014; HR 474: Homeless Veterans' Reintegration Programs Reauthorization Act of 2015; S 851: Caregivers Expansion and Improvement Act; HR 294: Long-Term Care Veterans Choice Act; HR 2072: Demanding Accountability for Veterans Act of 2013; PL 113-146: Veterans Access, Choice and Accountability Act of 2014; PL 113-175: Department of Veterans Affairs Expiring Authorities Act of 2014; PL 113-360: National Defense Authorization Act; and S 657 Caregivers Expansion & Improvement Act of 2015.

Client expense: $91,416 · Firm income: Not reported

Government targets: Administration for Children & Families (ACF), Defense, Dept of (DOD), Education, Dept of, Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Council on Disability, SENATE, Transportation, Dept of (DOT), U.S. Architectural & Transportation Barriers Compliance Board (ACCESS), Veterans Affairs, Dept of (VA), White House Office